Clinical Trial

A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 3, 2021 (before its estimated October 20, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled,parallel-group preliminary verifying study about safety and efficacy of maintenance DCVAC/OvCa after first-line chemotherapy added to standard of care in patients with newly diagnosed FIGO III-IV ovarian, fallopian tube, or primary peritoneal carcinoma.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-04-06; most recent amendment 2021-04-30.
Status change: Not Yet Recruiting → Recruiting 2021-04-30
Status change: Recruiting → Not Yet Recruiting 2021-04-13
Trial Details
NCT Number NCT04834544
Lead Sponsor Peking University Third Hospital
Collaborators: SOTIO a.s.
Conditions Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
Enrollment 75 participants
Start Date 2021-04-19
Primary Completion 2024-10-20 (estimated)
Study Completion 2027-04-20 (estimated)
Updated on ClinicalTrials.gov 2021-05-03